T

Take Ltd

Q2 FY27Healthcare Services

Take Q2 Results 2026: PAT ₹2 Cr −64.9%, Revenue ₹29 Cr

Q2 FY27 results statement: what the company reported on revenue, margins and capex.

Revenue
₹29Cr
Q2 FY26: ₹0 Cr
−3.1% QoQ
Net profit
₹2Cr
−64.9% YoY
+108.5% QoQ
Margin
6.1%
+7 pp QoQ

Take Ltd Q2 FY27 key numbers

Revenue
Standalone revenue from operations for the same quarter was Rs. 1,431.98 lakhs, also compared to Rs. 0 in the previous year quarter.

As stated in Take Ltd's Q2 FY27 results statement · published 14 Nov 2026. Reported figures, not investment advice.

Based on Take Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.

Price₹13
Market cap₹192 Cr
P/E32.5

The short version

For the quarter ended September 30, 2026, TAKE Limited reported consolidated revenue from operations of Rs. 2,941.68 lakhs versus Rs. 0 for the corresponding quarter in the previous year, indicating a. EBITDA for the quarter is ₹ 62.9 million, up 304% year-on-year (YoY).

From Take Ltd's Q2 FY27 earnings-call transcript · updated 14 Nov 2026.

How did Take's revenue grow in the September 2026 quarter?

  • For the quarter ended September 30, 2026, TAKE Limited reported consolidated revenue from operations of Rs. 2,941.68 lakhs versus Rs. 0 for the corresponding quarter in the previous year, indicating a significant year-on-year increase.
  • Standalone revenue from operations for the same quarter was Rs. 1,431.98 lakhs, also compared to Rs. 0 in the previous year quarter.

What happened to Take's margins in Q2 FY27?

See what Take Ltd said on profitability & margins — free account, 30 seconds.

What capex is Take planning?

See what Take Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Take raising money or cutting debt?

See what Take Ltd said on fundraising & capital structure — free account, 30 seconds.

How big is Take's order book?

See what Take Ltd said on order book & pipeline — free account, 30 seconds.

Take Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Take Ltd Q2 FY27 results — key figures

Take Ltd Q2 FY27 reported results vs Q2 FY26, ₹ crore
₹ CrQ2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue290—30-3.1%
Operating profit (EBITDA)2-0—-0—
Operating margin6.1%——-0.9%+7 pp
Profit before tax2-0—1+108.5%
Net profit (PAT)26-64.9%1+108.5%
EPS (₹)0.150.43-65.1%0.07+114.3%

Source: Take Ltd's results filing to NSE (consolidated), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹29 Cr, net profit ₹2 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

More Q2 FY27 results in Healthcare Services

All Q2 FY27 results | Healthcare Services rankings

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Take Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Take Ltd Q2 FY27 results?

Take reported net profit of ₹2 Cr (−64.9% YoY) on revenue of ₹29 Cr in Q2 FY27.

What is Take Ltd share price analysis?

Take Ltd currently shows a neutral. The stock trades at a P/E of 32.5 with a market cap of ₹192 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Take Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.